Cipher Pharmaceuticals (DND.TO) Completes Latin American Distribution and Supply Agreement for Extended-Release Tramadol
4/29/2013 10:53:36 AM
More...
|
Notice of Cipher Pharmaceuticals (DND.TO)Q1 2013 Conference Call and 2012 Annual and Special Meeting of Shareholders
4/16/2013 9:06:02 AM
More...
|
Notice of Cipher Pharmaceuticals (DND.TO) Q4 and Year-End 2012 Conference Call
2/21/2013 10:23:01 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Submits NDA Amendment For CIP-ISOTRETINOIN
11/28/2011 6:44:37 AM
More...
|
Notice of Cipher Pharmaceuticals (DND.TO) Fiscal 2011 Third Quarter Conference Call
10/19/2011 1:20:42 PM
More...
|
Cipher Pharmaceuticals (DND.TO) And Vertical Pharmaceuticals Complete U.S. Distribution And Supply Agreement For Extended-Release Tramadol
6/29/2011 7:40:51 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Acne Drug Shows Comparable Safety, Efficacy
6/7/2011 7:26:30 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Reports Fiscal 2010 Financial Results
3/9/2011 10:12:01 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Using MedAvante Centralized Ratings in Phase 3 Study
12/7/2010 10:00:58 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Reports Q2 2010 Financial Results
7/28/2010 11:30:55 AM
More...
|
|